Clinical outcome trial with IV iron in patients with iron deficiency, stabilized after acute HF

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
ESC Heart Failure 2025
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
- Felix Lindberg, MD, PhD
Greater benefit of empagliflozin in HFpEF patients with features of diastolic dysfunction
Greater benefit of empagliflozin in HFpEF patients with features of diastolic dysfunction
ESC Heart Failure 2025
Greater benefit of empagliflozin in HFpEF patients with features of diastolic dysfunction
- João Pedro Ferreira, MD, PhD
Finerenone does not alter vascular stiffness in patients with T2D and CKD
Finerenone does not alter vascular stiffness in patients with T2D and CKD
ESC Heart Failure 2025
Finerenone does not alter vascular stiffness in patients with T2D and CKD
- Atsushi Tanaka, MD, PhD